NMS Capital has exited its investment in Flourish Research, a US-based clinical trial organization, through a sale to Genstar Capital. No financial terms were disclosed.

Pending U.S. home sales rose 4.3% year over year during the four weeks ending November 3, in line with the increases Redfin has seen over the last six weeks. That's according to a new report from ...

Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal ...

A trio of research papers from Stanford Medicine researchers and their international collaborators transforms scientists' understanding of how small DNA circles -; until recently dismissed as ...

Amber Hill spent 14 years as a medical researcher. She didn't mind the work, but there was one thing she consistently hated: ...

SARS-CoV-2—initially thought of as an acute respiratory virus—can lead to post-COVID-19 condition (also known as long COVID), a chronic multisystemic illness that develops in some people who have been ...

A team of bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12) -- a potent immune-boosting protein that holds promise for cancer treatment -- loses effectiveness ...

Tiny circles called ecDNA are critical in cancer development and drug resistance. An international team publishes landmark studies detailing new findings and potential therapies.

Tetanus is a serious bacterial infection caused by Clostridium tetani, which affects the nervous system, leading to muscle stiffness and spasms. With an increased awareness of disease prevention, ...

Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading ...